EpCAM is a highly expressed marker in cancer, especially in circulating tumor cells (CTC), and is closely related to poor prognosis.212 Therefore, it is an interesting strategy to capture CTC based on anti-EpCAM antibody-modified nanomedicine. This evidence concerns the gene EPCAM and neoplasm.